- Home
- GSIW vs CDIO Comparison
GSIW vs CDIO Comparison
Compare GSIW & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSIW
- CDIO
- Stock Information
- Founded
- GSIW 2016
- CDIO 2017
- Country
- GSIW Hong Kong
- CDIO United States
- Employees
- GSIW N/A
- CDIO N/A
- Industry
- GSIW
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- GSIW
- CDIO Health Care
- Exchange
- GSIW Nasdaq
- CDIO Nasdaq
- Market Cap
- GSIW 10.5M
- CDIO 12.3M
- IPO Year
- GSIW 2023
- CDIO N/A
- Fundamental
- Price
- GSIW $0.57
- CDIO $0.90
- Analyst Decision
- GSIW
- CDIO Buy
- Analyst Count
- GSIW 0
- CDIO 1
- Target Price
- GSIW N/A
- CDIO $2.00
- AVG Volume (30 Days)
- GSIW 156.5K
- CDIO 12.3M
- Earning Date
- GSIW 12-31-2024
- CDIO 11-13-2024
- Dividend Yield
- GSIW N/A
- CDIO N/A
- EPS Growth
- GSIW N/A
- CDIO N/A
- EPS
- GSIW N/A
- CDIO N/A
- Revenue
- GSIW $1,408,469.00
- CDIO $35,688.00
- Revenue This Year
- GSIW N/A
- CDIO $2,093.61
- Revenue Next Year
- GSIW N/A
- CDIO $43.05
- P/E Ratio
- GSIW N/A
- CDIO N/A
- Revenue Growth
- GSIW N/A
- CDIO 180.90
- 52 Week Low
- GSIW $0.53
- CDIO $0.19
- 52 Week High
- GSIW $15.99
- CDIO $3.56
- Technical
- Relative Strength Index (RSI)
- GSIW 36.17
- CDIO 58.19
- Support Level
- GSIW $0.55
- CDIO $0.99
- Resistance Level
- GSIW $0.64
- CDIO $1.77
- Average True Range (ATR)
- GSIW 0.06
- CDIO 0.27
- MACD
- GSIW 0.04
- CDIO 0.04
- Stochastic Oscillator
- GSIW 16.67
- CDIO 41.73
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.